AGLIV-300

COMPOSITION
Ursodeoxycholic Acid 300 mg

Category

Hepatic Care (Hepatoprotective / Bile Acid)
Packing

SKU b336b3707ff0 Categories , , Tag

ENQUIRY

Indications
AGLIV-300 is clinically indicated for several complex conditions involving the liver and biliary system:

Cholesterol Gallstones: Specifically indicated for the dissolution of radiolucent, non-calcified gallstones in patients with a functioning gallbladder.

Primary Biliary Cirrhosis (PBC): Used as a primary treatment to slow disease progression and improve clinical symptoms in patients with early-stage PBC.

Bile Stasis (Cholestasis): Effective in managing hepatic disorders where bile flow is obstructed or slowed.

Chronic Liver Diseases: Provides supportive therapy for various long-term liver conditions to maintain organ integrity.

Toxic Bile Acid Protection: Counters the accumulation of hydrophobic bile acids that can cause cellular damage.

Gallstone Dissolution: Gradually reduces the cholesterol content in bile, allowing cholesterol-based gallstones to dissolve over time.

Biliary Cirrhosis Therapy: Helps manage the symptoms and biochemical markers associated with primary biliary cirrhosis.

Liver Function Optimization: Supports the improvement of overall liver enzyme profiles and physiological performance.

Cellular Protection: Acts as a shield for liver cells (hepatocytes), protecting them from the inflammatory and toxic damage caused by high concentrations of bile acids.

Standard Regimen: Generally prescribed as 2 to 3 doses per day, depending on the patient’s body weight and the specific condition being treated.

Dosing Frequency: For optimal therapeutic levels, a consistent gap of approximately 6 hours between doses is recommended.

Meal Coordination: The medication is best taken either with food or immediately following a meal to aid absorption.

Storage Temperature: Maintain in a dry environment at temperatures below 25°C.

Environmental Protection: Store away from direct sunlight and moisture to ensure chemical stability.

Packaging: Tablets should remain in their original blister pack until the exact moment of use.

Safety: Ensure the medication is stored in a location inaccessible to children and pets.

Administration: Swallow the tablet whole with a full glass of milk or water after eating.

Hydration: Maintain high fluid intake throughout the day to support the kidneys and help prevent potential diarrhea.

Dietary Support: Follow a liver-friendly, healthy diet and engage in regular exercise as recommended by your healthcare provider.

Compliance: Successful gallstone dissolution often requires long-term treatment; do not discontinue without medical advice.

Professional Oversight: AGLIV-300 must be used under strict medical supervision, especially in complex cases.

Liver Impairment: Patients with severe liver impairment require careful monitoring and frequent clinical assessment.

Pregnancy & Lactation: Use in pregnant or breastfeeding women should only be considered if the benefits outweigh the risks and under direct medical guidance.

Gallstone Type Restrictions: This medication is not recommended for patients with calcified (hardened) gallstones or pigment-based gallstones, as these will not dissolve.

Routine Testing: Regular monitoring of Liver Function Tests (LFTs) is essential to evaluate the efficacy and safety of the treatment.

Diarrhea
Skin Rash
Abdominal Discomfort
Nausea or Vomiting
Rarely: Gallstone Calcification, Elevated Liver Enzymes
The information provided is for educational and informational purposes only and is not intended as medical advice.
Always consult a healthcare professional for medical advice, diagnosis, or treatment.
Agnes Life Sciences does not claim that any of its products can diagnose, treat, cure or prevent any disease.
Indications
AGLIV-300 is clinically indicated for several complex conditions involving the liver and biliary system:

Cholesterol Gallstones: Specifically indicated for the dissolution of radiolucent, non-calcified gallstones in patients with a functioning gallbladder.

Primary Biliary Cirrhosis (PBC): Used as a primary treatment to slow disease progression and improve clinical symptoms in patients with early-stage PBC.

Bile Stasis (Cholestasis): Effective in managing hepatic disorders where bile flow is obstructed or slowed.

Chronic Liver Diseases: Provides supportive therapy for various long-term liver conditions to maintain organ integrity.

Toxic Bile Acid Protection: Counters the accumulation of hydrophobic bile acids that can cause cellular damage.

Uses

Gallstone Dissolution: Gradually reduces the cholesterol content in bile, allowing cholesterol-based gallstones to dissolve over time.

Biliary Cirrhosis Therapy: Helps manage the symptoms and biochemical markers associated with primary biliary cirrhosis.

Liver Function Optimization: Supports the improvement of overall liver enzyme profiles and physiological performance.

Cellular Protection: Acts as a shield for liver cells (hepatocytes), protecting them from the inflammatory and toxic damage caused by high concentrations of bile acids.

Dosage & Storage
Standard Regimen: Generally prescribed as 2 to 3 doses per day, depending on the patient’s body weight and the specific condition being treated.

Dosing Frequency: For optimal therapeutic levels, a consistent gap of approximately 6 hours between doses is recommended.

Meal Coordination: The medication is best taken either with food or immediately following a meal to aid absorption.

Storage Temperature: Maintain in a dry environment at temperatures below 25°C.

Environmental Protection: Store away from direct sunlight and moisture to ensure chemical stability.

Packaging: Tablets should remain in their original blister pack until the exact moment of use.

Safety: Ensure the medication is stored in a location inaccessible to children and pets.

Directions For Use
Administration: Swallow the tablet whole with a full glass of milk or water after eating.

Hydration: Maintain high fluid intake throughout the day to support the kidneys and help prevent potential diarrhea.

Dietary Support: Follow a liver-friendly, healthy diet and engage in regular exercise as recommended by your healthcare provider.

Compliance: Successful gallstone dissolution often requires long-term treatment; do not discontinue without medical advice.

Precautions
Professional Oversight: AGLIV-300 must be used under strict medical supervision, especially in complex cases.

Liver Impairment: Patients with severe liver impairment require careful monitoring and frequent clinical assessment.

Pregnancy & Lactation: Use in pregnant or breastfeeding women should only be considered if the benefits outweigh the risks and under direct medical guidance.

Gallstone Type Restrictions: This medication is not recommended for patients with calcified (hardened) gallstones or pigment-based gallstones, as these will not dissolve.

Routine Testing: Regular monitoring of Liver Function Tests (LFTs) is essential to evaluate the efficacy and safety of the treatment.

Side Effects
Diarrhea
Skin Rash
Abdominal Discomfort
Nausea or Vomiting
Rarely: Gallstone Calcification, Elevated Liver Enzymes
Medical Disclaimer
The information provided is for educational and informational purposes only and is not intended as medical advice.
Always consult a healthcare professional for medical advice, diagnosis, or treatment.
Agnes Life Sciences does not claim that any of its products can diagnose, treat, cure or prevent any disease.

ENQUIRY

Contact Us


    This will close in 0 seconds

    Download Product PDF


      This will close in 0 seconds

      Scroll to Top
      Phone WhatsApp Enquiry